Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies and Estimates - Narrative (Details)

v3.19.3.a.u2
Summary of Significant Accounting Policies and Estimates - Narrative (Details) - USD ($)
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Jan. 31, 2019
Jan. 01, 2019
Significant Accounting Policies [Line Items]        
Impairment loss on long-lived assets $ 0 $ 0    
Impairment loss on goodwill 0 0    
Government grant     $ 1,500,000  
Advertising costs 14,000 $ 123,000    
Right-of-use assets 1,084,000      
Lease liabilities $ 1,132,000      
Customer Concentration Risk | Accounts Receivable        
Significant Accounting Policies [Line Items]        
Concentration risk percentage 11.00% 19.00%    
Customer Concentration Risk | Revenue Benchmark        
Significant Accounting Policies [Line Items]        
Concentration risk percentage 15.00%      
Minimum        
Significant Accounting Policies [Line Items]        
Estimated life 3 years      
Accounts receivable payment terms 30 days      
Maximum        
Significant Accounting Policies [Line Items]        
Estimated life 10 years      
Accounts receivable payment terms 90 days      
EksoHealth | Minimum        
Significant Accounting Policies [Line Items]        
Accounts receivable payment terms 12 months      
EksoHealth | Maximum        
Significant Accounting Policies [Line Items]        
Accounts receivable payment terms 48 months      
Accounting Standards Update 2016-02        
Significant Accounting Policies [Line Items]        
Right-of-use assets       $ 1,454,000
Lease liabilities       $ 1,498,000